These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 53922)

  • 21. Donor reaction to hydroxyethyl starch during granulocytapheresis.
    Dutcher JP; Aisner J; Hogge DE; Schiffer CA
    Transfusion; 1984; 24(1):66-7. PubMed ID: 6198788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Granulocyte collection: a comparison of Fenwal CS 3000, IBM 2997, and haemonetics cell separators.
    Eckermann I; Strauss RG
    J Clin Apher; 1984; 2(1):26-31. PubMed ID: 6536656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selecting the optimal dose of low-molecular-weight hydroxyethyl starch (Pentastarch) for granulocyte collection.
    Strauss RG; Villhauer PJ; Imig KM; Eckermann I; Gupta SD; Thomson DS
    Transfusion; 1987; 27(4):350-2. PubMed ID: 2440159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Donor toxicity in granulocyte collections: association of lichen planus with the use of hydroxyethyl starch leukapheresis.
    Bode U; Deisseroth AB
    Transfusion; 1981; 21(1):83-5. PubMed ID: 6162256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The function and structure of granulocytes collected using the IBM 2997 separator.
    Wood L; Hester JP; Jacobs P
    J Clin Apher; 1984; 2(2):190-4. PubMed ID: 6085629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hydroxyethyl starch as an experimental adjunct to leukocyte separation by centrifugal means: review of safety and efficacy.
    Mishler JM
    Transfusion; 1975; 15(5):449-60. PubMed ID: 53917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adverse effects of granulocyte donations.
    Huestis DW
    Prog Clin Biol Res; 1982; 88():101-14. PubMed ID: 6179099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravascular persistence of hydroxyethyl starch (HES) after serial granulocyte collections using HES in man.
    Ring J; Sharkoff D; Richter W
    Vox Sang; 1980 Oct; 39(4):181-5. PubMed ID: 6163255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Harvesting of granulocytes for transfusion therapy by haemonetics 30. Yield, morphology and in vitro functions of collected granulocytes.
    Rosenkvist J; Behnke O; Johansen KS; Karle H; Nielsen OS; Sørensen H; Valerius NH
    Scand J Haematol; 1978 May; 20(5):453-60. PubMed ID: 208137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of pentastarch in granulocyte collection by centrifugal leukapheresis.
    Lee JH; Cullis H; Leitman SF; Klein HG
    J Clin Apher; 1995; 10(4):198-202. PubMed ID: 8770713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A pilot study on impact of use of medium molecular weight hydroxyethyl starch in granulocyte apheresis using Spectra Optia.
    Mandal S; Naim F; Kumar R; Gupta S; Gupta VR; Kathuria I
    Transfus Apher Sci; 2022 Oct; 61(5):103436. PubMed ID: 35361543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of donor red cell sedimentation rate on efficiency of granulocyte collection by centrifugal leukapheresis.
    Lee JH; Klein HG
    Transfusion; 1995 May; 35(5):384-8. PubMed ID: 7740608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plateletpheresis using the haemonetics model 30 cell separator.
    Nusbacher J; Scher ML; MacPherson JL
    Vox Sang; 1977 Jul; 33(1):9-15. PubMed ID: 883246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of a single or double dose of dexamethasone on granulocyte collection with the continuous flow centrifuge.
    Higby DJ; Mishler JM; Rhomberg W; Nicora RW; Holland JF
    Vox Sang; 1975; 28(3):243-8. PubMed ID: 1119136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and laboratory effects on donors of intermittent-flow centrifugation platelet-leukapheresis performed with hydroxyethyl starch and citrate.
    Strauss RG; Koepke JA; Maguire LC; Thompson JS
    Clin Lab Haematol; 1980; 2(1):1-11. PubMed ID: 6155239
    [No Abstract]   [Full Text] [Related]  

  • 36. Utilization of a new strength citrate anticoagulant during centrifugal plateletpheresis. I. Assessment of donor effects.
    Mishler JM; Janes AW; Lowes B; Farfan C; Emerson PM
    Br J Haematol; 1976 Nov; 34(3):387-94. PubMed ID: 990180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gravity sedimentation of granulocytapheresis concentrates with hydroxyethyl starch efficiently removes red blood cells and retains neutrophils.
    Bryant BJ; Yau YY; Byrne PJ; Stroncek DF; Leitman SF
    Transfusion; 2010 Jun; 50(6):1203-9. PubMed ID: 20113453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved granulocyte collection from normal donors by combination of continuous-flow centrifugation and filtration leukapheresis.
    Gmür JP; Deluigi J; Straub PW
    Transfusion; 1975; 15(6):565-9. PubMed ID: 1198684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of dextran 75 as a macromolecular agent in centrifugal leukapheresis.
    Huestis DW
    Transfusion; 1977; 17(2):156-8. PubMed ID: 66780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Granulocyte collection by polymorphonuclear cell-targeting apheresis with medium-molecular-weight hydroxyethyl starch.
    Henzan T; Yamauchi T; Yamanaka I; Sakoda T; Semba Y; Hayashi M; Kikushige Y; Mishima H; Ishimura M; Koga Y; Miyamoto T; Ohga S; Akashi K; Maeda T; Kunisaki Y
    Int J Hematol; 2021 Dec; 114(6):691-700. PubMed ID: 34453685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.